12
Participants
Start Date
September 30, 2014
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
PF-06372865
7.5 mg as 3 x 2.5 mg tablets single dose
PF-06372865
7.5 mg as 3 x 2.5 mg tablets single dose
Pfizer Clinical Research Unit, Brussels
Lead Sponsor
Pfizer
INDUSTRY